Infectious Disease

Top Story

PEPFAR, partners award $85 million to 56 entities to reduce HIV

July 24, 2016

The President’s Emergency Plan for AIDS Relief, or PEPFAR, along with Janssen Pharmaceuticals and ViiV Healthcare awarded $85 million to 56 DREAMS Innovation Challenge winners from sub-Saharan Africa, in an effort to reduce new HIV infection in young girls and women.

DREAMS is a $385 million partnership — led by PEPFAR with support from the Bill and Melinda Gates Foundation, Girl Effect, Gilead Sciences, Johnson & Johnson, and ViiV Healthcare — whose goal is to help girls develop into “Determined, Resilient, Empowered, AIDS-free, Mentored and Safe women,” according to the PEPFAR website. The 10 DREAMS countries include Kenya, Lesotho, Malawi, Mozambique, South Africa, Swaziland, Tanzania, Uganda, Zambia and Zimbabwe, and account for nearly half of all the new HIV infections that occurred among adolescent girls and young women globally in 2014.

AASLD/IDSA update HCV guidance

July 23, 2016
The American Association for the Study of Liver Diseases and the Infectious Diseases Society of America have released updated guidelines on their website for the…
In the Journals

EV-D68, acute flaccid myelitis linked during 2014 Colorado outbreak

July 22, 2016
Children with acute flaccid myelitis had a 10-fold greater risk for having enterovirus D68 infection during a cluster of cases in Colorado in 2014, according to recent…
In the Journals

Female physicians make 'substantially' less than male counterparts

July 22, 2016
Significant salary differences exist between male and female physicians at public medical schools, according to findings published in JAMA Internal Medicine. This gap…
Meeting News Coverage

Four fast-track cities announce 90-90-90 data on HIV/AIDS

July 22, 2016
Four cities that are part of a plan to end the HIV/AIDS epidemic in their communities by 2030 announced 90-90-90 data at AIDS 2016 in Durban, South Africa, this week…
More News Headlines »
CME

The Patient with HIV Infection

No commercial support for this activity.

The selection of the initial regimen is critical in that it is usually the longest duration regimen that a patient will…
More »
GI Bookshelf

Chapter 5: Dysplasia And Colorectal Cancer

From Clinical Challenges and Complications of IBD
More »
Featured
Zika Resource Center

Zika Resource Center

Video
Meeting News Coverage

VIDEO: Scott B. Halstead, MD, discusses Zika history

June 19, 2016
More »
morganatic-roan
morganatic-roan